Clinical Trial Update: A Study Evaluating Topical Recombinant Human Vascular Endothelial Growth Factor (Telbermin) for Induction of Healing of Chronic, Diabetic Foot Ulcers [Phase 1]

View source ↗

Summary

This clinical trial update reports on a Phase 1 study evaluating Telbermin, a topical recombinant human vascular endothelial growth factor, for healing chronic …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Foot Ulcer

Drugs mentioned

• Telbermin (recombinant human vascular endothelial growth factor)

Snippet

Sponsor: Genentech, Inc. | Conditions: Foot Ulcer | Phase 1 | Status: COMPLETED